Bruker Corporation

$56.86-$0.81 (1.4%)

Estimate

EPS

-0.73

Beta

1.275

Growth

Revenue, YoY

5.15%

Net income, YoY

-784.21%

FCF, YoY

28.63%

Forecast

P/E (FWD)

23.4

EPS (FWD)

2.429

Dividends

Dividend yield

0.35%

Annual payout

$0.20

Next ex. div date

September 21, 26

Div.growth, 5y

4.56%

Div.rating

About the company

Ticker

BRKR

ISIN

US1167941087

Country

United States of America

Sector (GICS)

Healthcare

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Frequently asked questions

What sector does Bruker Corporation (BRKR) operate in?

Bruker Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Bruker Corporation (BRKR) current stock price?

As of the latest data, Bruker Corporation stock price is $56.86, with a previous close of $57.67. Bruker Corporation lost -$0.81 in the last trading session, representing a -1.4% loss.

What is Bruker Corporation (BRKR) current market capitalization?

Bruker Corporation market cap is approximately 8.66 billion.

What is Bruker Corporation (BRKR) Earnings Per Share (EPS)?

The trailing EPS is -$0.73, and the forward EPS is $2.43.

What is Bruker Corporation (BRKR) EBITDA?

Bruker Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 17.30 million.

Does Bruker Corporation (BRKR) pay dividends?

Yes. Bruker Corporation pays quarterly dividends with an annualized yield of 0.35% and an estimated annual payout of $0.20 per share.

When is the next ex-dividend date for Bruker Corporation (BRKR)?

The next ex-dividend date is scheduled for September 21, 2026.

How did Bruker Corporation (BRKR) perform in its most recent earnings report?

In the last report (June 30, 2026), Bruker Corporation posted an EPS surprise of 28.95% and a revenue surprise of -1.77%.

What is Bruker Corporation (BRKR) beta (volatility) score?

Bruker Corporation has a beta of 1.275, suggesting it is more volatile than the market.